AccessibilityHelp
Stevanato Group S.p.A. logo

Stevanato Group S.p.A.(NYSE) STVN

Market Cap$5.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)+1%
5 Year-20%
1 Year-29%
1 Month-10%
Premium Feature
Moneyball Superscore
71/100
$19.66
+0.87%
+0.17Today
Stevanato Group S.p.A. last closing stock price
MetricPriceDate
Last closeUSD 19.492026-10-23
Stevanato Group S.p.A. stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.12%USD 18.902026-10-16
1 month-10.14%USD 21.692026-09-23
3 month-0.97%USD 19.682026-07-24
Year to date-2.78%USD 20.052025-12-31
1 year-29.15%USD 27.512025-10-23
3 year-39.66%USD 32.302023-10-24
5 year-20.46%USD 24.502021-10-22
Since inception+0.58%USD 19.382021-07-16

Stevanato Group S.p.A. Financials at a Glance

Market Cap

$5.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€1.22B

Net Income (TTM)

€134.25M

EPS (TTM)

$0.58

P/E Ratio

33.88

Dividend

$0.06

Beta (Volatility)

0.89 (Low)

Price

$19.66

Volume

60,246.326

Open

$19.47

Previous Close

$19.49

Daily Range

$18.94 - $19.71

52-Week Range

$12.89 - $27.00

Estimated Earnings Date

Nov 3, 2026

STVN News

No articles available.

STVN: Motley Fool Moneyball Superscore

71

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Stevanato Group S.p.A.

Stevanato Group S.p.A. is a leading provider of integrated solutions for the pharmaceutical and healthcare sectors. Established in 1949, the company specializes in engineering, manufacturing, and distributing a diverse range of products, including containment solutions, drug delivery systems, and medical devices.

Products and Services
  • Containment solutions for pharmaceuticals
  • Drug delivery systems and medical devices
  • Specialized machinery for inspection and packaging
Growth Outlook
  • Revenue increased to €302 million in Q2 2026
  • Consistent growth in net income, reaching €23 million in Q2 2026
  • Strong demand for healthcare solutions supports future expansion
Financial Highlights
  • Trailing twelve-month revenue of €1.2 billion
  • Net profit margin of 10.99% reflects operational efficiency
  • Operating income of €39 million in Q2 2026
Stevanato Group S.p.A. operates in a robust market, driven by increasing healthcare demands and innovations in drug delivery systems. The company's recent financial performance indicates a solid growth trajectory, with significant revenue and net income increases. The diverse product offerings and specialized machinery position Stevanato Group favorably within the healthcare sector, making it an attractive option for potential investors.
AI Generated • Oct 19, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

CEO

Franco Stevanato

Website

www.stevanatogroup.com

Headquarters

Piombino Dese, PD 35017, IT

STVN Financials

Key Financial Metrics (TTM)

Gross Margin

29.16%

Operating Margin

16.08%

Net Income Margin

10.99%

Return on Equity

8.94%

Return on Capital

9.36%

Return on Assets

5.13%

Earnings Yield

2.95%

Dividend Yield

0.32%

Payout Ratio

0.04%

Stock Overview

Market Cap

$5.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

273.00M

Volume

60.25K

Avg. Volume

395.09K

Financials (TTM)

Gross Profit

€356.38M

Operating Income

€196.53M

EBITDA

€296.36M

Operating Cash Flow

€247.03M

Capital Expenditure

-€272.65M

Free Cash Flow

-€25.62M

Cash & ST Invst.

€83.58M

Total Debt

€442.99M

Stevanato Group S.p.A. Performance Analysis

Stevanato Group S.p.A. annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 1,033,822,4163.6%
20232023-12-31EUR 1,173,393,14413.5%
20242024-12-31EUR 1,194,225,5361.8%
20252025-12-31EUR 1,338,811,70812.1%
Stevanato Group S.p.A. sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-308.3%
Q42025-12-3113.2%
Q12026-03-31-20.3%
Q22026-06-3010.4%
Stevanato Group S.p.A. annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 0.57-5.4%
20232023-12-31EUR 0.594.8%
20242024-12-31EUR 0.47-20.9%
20252025-12-31EUR 0.5823.1%
Stevanato Group S.p.A. sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3018.2%
Q42025-12-3130.8%
Q12026-03-31-41.2%
Q22026-06-30-20.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€302.00M

+7.8%

Gross Profit

€86.80M

+10.5%

Gross Margin

28.74%

N/A

Market Cap

$5.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$885.33K

N/A

Employees

6,010

N/A

Net Income

€23.00M

-22.6%

EBITDA

€64.29M

+3.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€83.58M

-11.2%

Total Debt

€442.99M

+6.8%

Accounts Receivable

€539.66M

+12.2%

Inventory

€309.00M

+12.7%

Long Term Debt

€319.04M

-6.6%

Short Term Debt

€123.95M

+69.0%

Return on Assets

5.13%

N/A

Return on Invested Capital

9.63%

N/A

Free Cash Flow

-€33.87M

-120.6%

Operating Cash Flow

€31.86M

-29.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MMSIMerit Medical Systems, Inc.
$94.22+0.98%
TFXTeleflex Incorporated
$136.34+0.04%
BLCOBausch + Lomb Corporation
$17.62+0.86%
CHEChemed Corporation
$515.53+0.50%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$12.40-18.24%
EWZiShares - iShares Msci Brazil ETF
$33.21-22.04%
ITUBItaú Unibanco
$7.54-22.03%
XPXP
$15.69-48.42%

Questions About STVN

What is the current price of Stevanato Group S.p.A.?

Stevanato Group S.p.A. is trading at $19.56 per share.

What is the 52-week range for Stevanato Group S.p.A.?

Over the past 52 weeks, Stevanato Group S.p.A. has traded between $12.89 and $27.00.

How much debt does Stevanato Group S.p.A. have?

As of the most recent reporting period, Stevanato Group S.p.A. reported total debt of €506.47M.

How much cash does Stevanato Group S.p.A. have on hand?

Stevanato Group S.p.A. reported €89.91M in cash and cash equivalents in its most recent financial results.

What is Stevanato Group S.p.A.’s dividend yield?

Stevanato Group S.p.A. currently has a dividend yield of 0.32%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services